GlassScriptPhysician profile
Stephen F Kitchen
NPI 1780616904
$7,175.59
in general payments reported to CMS, 2019-2025
17 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,205 · 2020: $325 · 2021: $259 · 2022: $394 · 2023: $218 · 2024: $428 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,323.36 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $578.40 | 2021-2024 | Venclose Maven Catheter |
| Becton, Dickinson and Company | $296.49 | 2025 | Venclose Maven Catheter |
| Medtronic, INC. | $238.20 | 2022-2025 | Venaseal, Symbotex, Closurefast |
| Venclose INC. | $190.75 | 2020 | |
| Tela Bio, INC. | $122.29 | 2021-2024 | Ovitex 2s |
| Medtronic Vascular, INC. | $93.34 | 2019-2020 | |
| Covidien LP | $87.21 | 2019 | |
| Davol INC. | $62.55 | 2022-2023 | Arista Ah Flexitip |
| Kerecis Limited | $37.56 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $35.22 | 2022 | |
| Novo Nordisk INC | $24.26 | 2024 | Rybelsus, Ozempic |
| Organogenesis INC. | $23.04 | 2023 | Puraply |
| Baudax Bio INC. | $19.78 | 2021 | |
| Acacia Pharma INC | $16.25 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.00 | 2024 | Varithena Administration Pack |
| Cashflow Solutions, LLC | $11.89 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kitchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.